• English
    X

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    main_ambulatory_care.jpg

      ALERTS


    • Life Threatening Vascular Access Hemorrhage Prevention Statement

    Patients with end-stage kidney failure frequently require hemodialysis, a medical treatment that replaces the function of the kidneys by filtering blood and removing waste products. The site at which blood is removed from and returned to the body is called a vascular access site, which is typically created through a graft, fistula or a central venous catheter. Vascular access sites are associated with many potential complications, including infection and blood clotting. Severe hemorrhagic shock or death from excessive blood loss is one of the most serious and preventable of these complications. It can occur when a blood vessel graft or AV fistula erodes through the skin, a false aneurysm develops at the access site, or a central venous catheter is accidentally cut or dislodged. Use of any vascular access by untrained individuals for blood sampling, intravenous substance abuse by dialysis patients, or access site infections are other important factors, which may result in vascular access failures, potentially fatal hemorrhages or overwhelming septicemia.

    Lethal vascular access related hemorrhagic complications occur in a very small percentage of hemodialysis patients. According to a recent study, 24 Maryland residents between 28 and 85 years of age died as a result of severe and uncontrolled bleeding from vascular access sites between the years 2000 and 2006. Of these patients, 63% were male and 75% were African American. 

    Some deaths from vascular access hemorrhage may have been preventable. An essential component of patient care is education, and hemodialysis patients should have repeated educational sessions concerning the clinical signs of vascular access site complications, including graft failure, infection or aneurysm formation. They also need to be clearly instructed that their vascular access is their dialysis lifeline and should only be used for treatment purposes by trained personnel for dialysis exclusively. 

    Furthermore, we recommend that nephrologists, vascular access surgeons and dialysis centers provide ongoing education on the risks of vascular access hemorrhage and the warning signs of graft failures. A more comprehensive policy on life saving measures in the event of severe hemorrhage from a vascular access site will be developed by the professional dialysis community in cooperation with the Maryland Kidney Commission​